3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
9
Pancreatic Neoplasms
8
Rectal Neoplasms
5
Urinary Bladder Neoplasms
4
Stomach Neoplasms
4
Colonic Neoplasms
3
Adenocarcinoma Of Esophagus
3
Squamous Cell Carcinoma of Head and Neck
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Clinical Stage I Gastric Cancer AJCC v8
2
Cholangiocarcinoma
2
Appendiceal Neoplasms
2
Anus Neoplasms
2
Uterine Neoplasms
1
Tongue Neoplasms
1
Sinonasal undifferentiated carcinoma
1
Salivary Gland Neoplasms
1
Peritoneal Neoplasms
1
Paranasal Sinus Neoplasms
1
Pancreatic Intraductal Neoplasms
1
Pancreatic Adenocarcinoma
1
PRETEXT I Hepatoblastoma
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Metastatic Small Intestinal Adenocarcinoma
1
Lymphoid Interstitial Pneumonia
1
Laryngeal Neoplasms
1
Interventions
fludarabine
52
Cyclophosphamide
50
venetoclax
47
Azacitidine
44
fludarabine phosphate
41
Whole-Body Irradiation
33
Specimen Handling
31
Mycophenolic Acid
30
Tacrolimus
28
Melphalan
28
Busulfan
27
Cytarabine
25
Stem Cell Transplantation
23
Decitabine
23
Biopsy
22
Granulocyte Colony-Stimulating Factor
19
Sirolimus
16
Peripheral Blood Stem Cell Transplantation
16
Filgrastim
16
Thiotepa
15
decitabine and cedazuridine drug combination
14
Injections
13
Cyclosporine
13
ruxolitinib
9
Methotrexate
9
Mesna
9
Hematopoietic Stem Cell Transplantation
9
X-Rays
8
Idarubicin
8
Daunorubicin
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
dehydroftorafur
×
1 year
×
Clear all
No trials found.